HEALTHSTAT NEWS
STAT+: Global coalition to fast-track three vaccines targeting Ebola outbreak with $62 million in funding
A global coalition is fast-tracking three vaccines targeting the Bundibugyo ebolavirus, with $62 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI). The current outbreak in the Democratic Republic of Congo lacks a licensed vaccine, as Merck’s Ervebo only targets the Zaire ebolavirus.
Mentioned
Related Signal
Adjacent reporting
- STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more
- These researchers would be in Africa fighting ebola—but Trump cut their funding
- Three Ebola vaccines in development amid growing outbreak fears
- Three Ebola vaccines in development amid growing outbreak fears
- Oxford scientists developing new vaccine to tackle Ebola outbreak within months
- WHO chief says Ebola outbreak in Congo is ‘spreading rapidly’ and upgrades risk assessment